Surge Nabs $2.6M Pre-Seed Financing
Summary
The round was co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture Partners, a leading fund based in the Silicon Valley. Veteran angel investors, including Nicolas Godin, the COO/CFO of Cardiologs, also participated in the round. Surge is a biotech company focused on optimizing treatment for patients undergoing surgery. Our multidisciplinary team has developed a test to identify patients at risk for complications. By anticipating surgical risks to enable personalization of the care pathway, this innovation will revolutionize the patient experience and shift the standard of surgical care.
Funding
Amount
$2.6M
Total raised
Date
September 2, 2022
Announcement date
Investors
Video Island
Lead investors
Company
https://www.surge.care/
Funded company
Classifications
industries
Fintech & Banking
applications
Accounting and Taxes
AskAI Classifications
Labels
No AI classifications detected